Sapience Therapeutics, Inc.
Jim Rotolo is currently the Senior Vice President of Research and Translational Sciences at Sapience Therapeutics, Inc. Prior to this, Jim held various research and leadership roles at ContraFect Corp and Ceramide Therapeutics, LLC. Jim's academic background includes a Ph.D. in Molecular Pharmacology from Cornell University. Jim's work has focused on developing peptide therapeutics for high mortality cancers and targeting the ceramide signaling pathway for medical radiation countermeasures and autoimmune indications.
This person is not in any offices